During this process, immune checkpoints, such as cytotoxic T lymphocytic protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1), on immune cell surfaces have been actively targeted to boost the immune system and for anti-tumor immunotherapies [4]. This evidence concerns the gene PDCD1 and neoplasm.